Overview

To Assess Bioequivalence of Loratadine Oral Solution/Syrup Versus Claritin Peach Syrup

Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
To assess the bioequivalence of Loratadine Oral Solution/Syrup 1mg/mL (GPLA Formula) versus Claritin Peach Syrup 1mg/mL (ANNA Formula)
Phase:
Phase 1
Details
Lead Sponsor:
Bayer
Treatments:
Loratadine
Pharmaceutical Solutions